| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.21 | 0.002 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |